✉news BusinessStartups first seen 6 h ago, last 2 h ago, peak #21

OpenAI leads $150M round for drug-reviving startup Biossil

OpenAI has led a $150 million funding round for Biossil, a startup working on reviving discontinued drugs. The deal marks a further push by OpenAI into applying its technology beyond core AI products, with biotech being a notable target area.

Why now: OpenAI's move into biotech investing is an unexpected expansion for a leading AI company, drawing wide attention.

OpenAIBiossil

Open on news →

Evidence

• OpenAI leads $150M round for drug-reviving startup Biossil · Dealroom.co

API: https://socialmediatrends-api.osmike.com/v1/trends/248746